Abbott India
- Advice
- Hold
Abbott India Performance
Day Range
- Low 22359
- High 22938
52 Week Range
- Low 17481.8
- High 24744.25
- Open Price22838.35
- Previous Close22838.35
- Volume9333
Start SIP in Abbott India
Start SIPAbbott India Investment Rating
-
Master Rating:
-
Abbott India has an operating revenue of Rs. 5,528.04 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 24% is great, ROE of 29% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 1,479 | 1,343 | 1,326 | 1,379 | 1,304 | 1,255 |
Operating Expenses Qtr Cr | 1,124 | 1,063 | 1,010 | 1,036 | 1,034 | 961 |
Operating Profit Qtr Cr | 355 | 280 | 316 | 343 | 270 | 294 |
Depreciation Qtr Cr | 17 | 17 | 18 | 17 | 17 | 17 |
Interest Qtr Cr | 3 | 4 | 4 | 4 | 4 | 5 |
Tax Qtr Cr | 100 | 77 | 88 | 90 | 70 | 81 |
Net Profit Qtr Cr | 290 | 231 | 247 | 266 | 206 | 211 |
Abbott India Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹23066.87
- 50 Day
- ₹23130.86
- 100 Day
- ₹22815.39
- 200 Day
- ₹22017.76
- 20 Day
- ₹23025.42
- 50 Day
- ₹23368.29
- 100 Day
- ₹22815.2
- 200 Day
- ₹22069.47
Abbott India Resistance and Support
Resistance | |
---|---|
First Resistance | ₹22867.84 |
Second Resistance | ₹23192.42 |
Third Resistance | ₹23446.84 |
RSI | 38.53 |
MFI | 63.31 |
MACD Single Line | -111.16 |
MACD | -121.71 |
Support | |
---|---|
First Resistance | ₹22288.84 |
Second Resistance | ₹22034.42 |
Third Resistance | ₹21709.84 |
Abbott India Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 10,001 | 392,839 | 39.28 |
Week | 9,604 | 415,543 | 43.27 |
1 Month | 13,442 | 707,562 | 52.64 |
6 Month | 12,480 | 612,892 | 49.11 |
Abbott India Result Highlights
Abbott India Synopsis
NSE-Medical-Diversified
Abbott India Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 5348.73 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2023. Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330.Market Cap | 47,810 |
Sales | 5,528 |
Shares in Float | 0.53 |
No of funds | 78 |
Yield | 0.79 |
Book Value | 15.22 |
U/D Vol ratio | 1 |
LTDebt / Equity | |
Alpha | 0.09 |
Beta | 0.35 |
Abbott India
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 74.99% | 74.99% | 74.99% | 74.99% |
Mutual Funds | 7.27% | 6.88% | 6.41% | 5.67% |
Insurance Companies | 1.38% | 1.59% | 1.84% | 2.04% |
Foreign Portfolio Investors | 0.19% | 0.19% | 0.2% | 0.2% |
Financial Institutions/ Banks | 0.02% | 0.02% | 0.02% | 0.02% |
Individual Investors | 13.95% | 14.07% | 14.25% | 14.6% |
Others | 2.2% | 2.26% | 2.29% | 2.48% |
Abbott India Management
Name | Designation |
---|---|
Mr. Munir Shaikh | Chairman |
Mr. Vivek V Kamath | Managing Director |
Mr. Rajiv Sonalker | WholeTime Director & CFO |
Mr. Kaiyomarz Marfatia | Non Executive Director |
Mr. Ambati Venu | Non Executive Director |
Mr. Sabina Ewing | Non Executive Director |
Mr. Sudarshan Jain | Independent Director |
Ms. Anisha Motwani | Independent Director |
Ms. Shalini Kamath | Independent Director |
Abbott India Forecast
Price Estimates
Abbott India Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-09 | Quarterly Results | |
2023-05-19 | Audited Results & Final Dividend | |
2023-02-10 | Quarterly Results | |
2022-11-14 | Quarterly Results | |
2022-08-10 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-07-21 | FINAL | Rs.180.00 per share(1800%)Final Dividend |
2023-07-21 | SPECIAL | Rs.145.00 per share(1450%)Special Dividend |
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1453
- 2.9
- Maruti Suzuki
- 10535
- 2.4
- St Bk of India
- 598
- 1.7
- M & M
- 1607
- 1.5
- Bajaj Finserv
- 1544
- 1.1
- Company Name
- CMP
- Chg(%)
Abbott India FAQs
What is Share Price of Abbott India ?
Abbott India share price is ₹22543 As on 22 September, 2023 | 22:51
What is the Market Cap of Abbott India ?
The Market Cap of Abbott India is ₹47902.8 Cr As on 22 September, 2023 | 22:51
What is the P/E ratio of Abbott India ?
The P/E ratio of Abbott India is 46.3 As on 22 September, 2023 | 22:51
What is the PB ratio of Abbott India ?
The PB ratio of Abbott India is 15 As on 22 September, 2023 | 22:51